Previous Close | 2.5300 |
Open | 2.5200 |
Bid | 2.8200 x 4000 |
Ask | 2.8400 x 1800 |
Day's Range | 2.4700 - 2.9199 |
52 Week Range | 2.1200 - 9.6000 |
Volume | |
Avg. Volume | 7,320,529 |
Market Cap | 668.76M |
Beta (5Y Monthly) | 4.32 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0540 |
Earnings Date | Aug 12, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.69 |
Subscribe to Yahoo Finance Plus to view Fair Value for SNDL
Sundial Growers (NASDAQ: SNDL) is pretty controversial for a cannabis stock. Between its meme-driven heyday in 2021 and its subsequent (and unexpected) pivot into marijuana investment banking, the one thing it can't seem to do is make a profit by selling cannabis. In that vein, here are three things that smart investors understand about the stock and what might make it worth a contrarian purchase.
With shares trading at more than $2 late last month, investors of SNDL (NASDAQ: SNDL), formerly known as Sundial Growers, may have gotten excited that there was some great news that finally lifted the stock up in value. It was a move the company needed to get its share price back over $1 and thus remain listed on the Nasdaq. Shares of SNDL have been falling again since the reverse split, and it's now down more than 70% over the past 12 months (by comparison, the Horizons Marijuana Life Sciences ETF has declined over 60%).
SNDL Inc. (formerly known as Sundial Growers Inc.) (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that it will release its second quarter financial results ended June 30, 2022, after market close on Friday, August 12, 2022.